Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Oruka Therapeutics, Inc. (ORKA) Institutional Ownership & Insider Trading

256 institutions reported holding Oruka Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 122 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ORKAOruka Therapeutics, Inc.Follow ORKA — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
5.3B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
18 Nov, in 25 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

256 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +38.0%.

Increased+92New+92Decreased-45Closed-24

Largest moves, shares (millions)

Capital World Investors+3.4MFMR+1.6MRa Capital Management+1.6MViking Global Investors-1.2MMercer Global Advisors Inc…-0.8MAvidity Partners Management-0.8M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Sep 24+6.5Dec 24+0.6Mar 25+2.7Jun 25+11.1Sep 25+5.6Dec 25+1.0Mar 26+20.0Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2625674+38.0%92924524
Mar 2618453+2.1%60532917
Dec 2514153+12.2%5038177
Sep 2510246+32.4%2930218
Jun 258134+8.4%24251313
Mar 257132+2.1%26151010
Dec 246631+26.9%192683
Sep 244125—————

Oruka Therapeutics, Inc. — questions

Who owns Oruka Therapeutics, Inc. stock?
256 institutions reported Oruka Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (13.7%), BlackRock, Inc. (7.5%), Venrock Adviser, LLC (6.3%).
Are Oruka Therapeutics, Inc. insiders buying or selling?
122 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Oruka Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.